創傷性腦損傷評估市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Traumatic Brain Injuries Assessment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月07日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球創傷性腦損傷(TBI) 評估市場估值為29 億美元，預計2024 年至2032 年複合年成長率為7.4%。上升、人口老化、與運動相關的頭部損傷增加，以及醫療保健支出增加。

TBI 由事故、跌倒、運動傷害或暴力引起，是全世界發病和死亡的主要原因。有效的評估工具對於及時診斷和管理 TBI 至關重要。神經影像（MRI、CT 掃描）、生物標記識別和可攜式診斷設備的最新技術進步顯著提高了 TBI 評估的速度、準確性和便利性。這些創新增強了醫療保健專業人員更有效地診斷和管理 TBI 的能力，從而改善患者的治療效果並促進市場成長。

TBI評估涉及評估外力引起的腦損傷，通常透過臨床評估、神經影像學和生物標記分析來評估損傷嚴重程度並指導治療。

市場主要分為兩大類產品：篩選設備和監控設備。包括 CT 和 MRI 掃描在內的篩檢設備在 2023 年創造了 23 億美元的收入，處於市場領先地位。監測設備重點在於顱內壓 (ICP) 和腦組織中的氧分壓 (pBrO2)。

人們對運動相關腦震盪及其長期影響的認知不斷提高，推動了篩檢設備的採用，特別是在體育組織、教育機構和專業團隊中。技術進步也促進了攜帶式神經影像工具和手持設備的發展，增強了 TBI 的檢測和評估，進一步推動了篩選設備市場的發展。

醫院作為 TBI 病例的主要照護端，在 2023 年成為主要的最終使用領域，預計到 2032 年市場價值將達到 32 億美元。並改善患者治療效果。

2023年，北美以12億美元的收入引領TBI評估市場。該地區強大的醫療基礎設施、先進的醫療技術以及神經影像和攜帶式診斷工具的持續創新奠定了其主導地位。北美對先進診斷方法和醫療設備創新的關注確保了持續成長，預計到 2032 年複合年成長率為 6.8%。

產業生態系統分析
產業影響力
- 成長動力
  - 創傷性腦損傷的發生率不斷上升
  - 創傷性腦損傷評估的技術進步
  - 對用於 TBI 評估的非侵入性設備的需求不斷增加
  - 對創傷性腦損傷的認知不斷提高
- 產業陷阱與挑戰
  - 缺乏熟練的專業人員
  - 評估設備成本高
成長潛力分析
監管環境
技術景觀
2023 年定價分析
價值鏈分析
差距分析
主要市場趨勢
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
篩選裝置
- 電腦斷層掃描 (CT) 掃描
- 磁振造影 (MRI)
- 其他篩選設備
監控設備
- 顱內壓 (ICP) 監測
- 腦組織中的氧分壓 (pBrO2)

第 6 章：市場估計與預測：依最終用途，2021 - 2032 年

主要趨勢
醫院
診斷中心
其他最終用戶

第 7 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

Accuray Incorporated
Asahi Kasei Corporation
BrainScope, Inc.
Compumedics Ltd.
CurveBeam AI, Ltd.
FUJIFILM Holdings Corporation
GE Healthcare
InfraScan, Inc.
Koninklijke Philips NV
Natus Medical, Inc.
Neusoft Corporation
Nihon Kohden Corporation
Oculogica
Raumedic AG
Siemens Healthineers AG

簡介目錄

Product Code: 5931

The Global Traumatic Brain Injury (TBI) Assessment Market was valued at USD 2.9 billion in 2023, with a projected CAGR of 7.4% from 2024 to 2032. Key factors driving this growth include advancements in diagnostic technologies, rising TBI incidences, an aging population, an increase in sports-related head injuries, and expanding healthcare expenditures.

TBIs, which result from accidents, falls, sports injuries, or violence, are a leading cause of morbidity and mortality worldwide. Effective assessment tools are crucial for the timely diagnosis and management of TBIs. Recent technological advancements in neuroimaging (MRI, CT scans), biomarker identification, and portable diagnostic devices have significantly improved the speed, accuracy, and convenience of TBI assessments. These innovations enhance healthcare professionals' ability to diagnose and manage TBIs more efficiently, leading to improved patient outcomes and contributing to market growth.

TBI assessment involves evaluating brain injuries caused by external forces, typically through clinical evaluations, neuroimaging, and biomarker analysis, to assess injury severity and guide treatment.

The market is divided into two main product categories: screening devices and monitoring devices. Screening devices, which include CT and MRI scans, generated USD 2.3 billion in 2023, leading the market. Monitoring devices focus on intracranial pressure (ICP) and the partial pressure of oxygen in brain tissue (pBrO2).

The increasing awareness of sports-related concussions and their long-term effects has driven the adoption of screening devices, particularly within sports organizations, educational institutions, and professional teams. Technological advancements have also led to the development of portable neuroimaging tools and handheld devices, which enhance the detection and assessment of TBIs, further driving the market for screening devices.

Hospitals, as the primary point of care for TBI cases, emerged as the dominant end use segment in 2023, with projections suggesting a market value of USD 3.2 billion by 2032. Hospitals rely heavily on advanced diagnostic tools to deliver swift and accurate TBI diagnoses, supporting specialized care and improving patient outcomes.

In 2023, North America led the TBI assessment market with USD 1.2 billion in revenue. The region's robust healthcare infrastructure, advanced medical technologies, and continuous innovations in neuroimaging and portable diagnostic tools contribute to its dominant position. North America's focus on advanced diagnostic methods and medical device innovations ensures continued growth, with a projected CAGR of 6.8% through 2032.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing incidence of traumatic brain injuries
  - 3.2.1.2 Technological advancements in traumatic brain injuries assessment
  - 3.2.1.3 Increasing demand for non-invasive devices for TBI assessment
  - 3.2.1.4 Rising awareness regarding traumatic brain injury
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Dearth of skilled professionals
  - 3.2.2.2 High cost of assessment devices
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pricing analysis, 2023
3.7 Value chain analysis
3.8 Gap analysis
3.9 Key market trends
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Screening devices
- 5.2.1 Computerized tomography (CT) scan
- 5.2.2 Magnetic resonance imaging (MRI)
- 5.2.3 Other screening devices
5.3 Monitoring devices
- 5.3.1 Intracranial pressure (ICP) monitoring
- 5.3.2 Partial pressure of oxygen in brain tissue (pBrO2)

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospitals
6.3 Diagnostic centers
6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa